Eliem Therapeutics Inc Free Cash Flow Per Share 3 year CAGR is -51.53% for the quarter ending March 31, 2024, a -222.20% change year over year. Free Cash Flow per Share represents the amount of free cash flow generated per outstanding share of common stock. It provides insight into the per-share value of free cash flow and is commonly used in valuation analysis. A higher value suggests a potentially more favorable investment opportunity. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.